Max Haid

418 total citations
28 papers, 295 citations indexed

About

Max Haid is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Max Haid has authored 28 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 7 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Max Haid's work include Lung Cancer Diagnosis and Treatment (3 papers), Bladder and Urothelial Cancer Treatments (3 papers) and CNS Lymphoma Diagnosis and Treatment (2 papers). Max Haid is often cited by papers focused on Lung Cancer Diagnosis and Treatment (3 papers), Bladder and Urothelial Cancer Treatments (3 papers) and CNS Lymphoma Diagnosis and Treatment (2 papers). Max Haid collaborates with scholars based in United States, Saudi Arabia and Germany. Max Haid's co-authors include Janardan D. Khandekar, Nehama Sharon, Michael Christ, R E Larson, Gershon Y. Locker, Stephen Sener, Santhosh Kumar, Joseph L. Feldman, Bruce Brockstein and David J. Winchester and has published in prestigious journals such as JAMA, Cancer and Journal of the American College of Surgeons.

In The Last Decade

Max Haid

27 papers receiving 284 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Max Haid United States 9 128 95 84 41 32 28 295
Michael J. Warzynski United States 11 146 1.1× 90 0.9× 116 1.4× 51 1.2× 25 0.8× 23 463
Gareth Rees United Kingdom 10 209 1.6× 172 1.8× 81 1.0× 22 0.5× 39 1.2× 21 403
Lisa Y. Law United States 8 113 0.9× 49 0.5× 55 0.7× 28 0.7× 28 0.9× 21 279
Stephen E. Fleming United States 10 143 1.1× 123 1.3× 74 0.9× 26 0.6× 23 0.7× 13 379
Carrye Cost United States 12 83 0.6× 102 1.1× 95 1.1× 41 1.0× 17 0.5× 39 299
L.T. Vlasveld Netherlands 11 150 1.2× 81 0.9× 65 0.8× 43 1.0× 5 0.2× 16 295
Maurizio Leoni Italy 11 168 1.3× 95 1.0× 43 0.5× 17 0.4× 11 0.3× 21 290
Joo Young Jung South Korea 11 150 1.2× 138 1.5× 86 1.0× 19 0.5× 14 0.4× 41 300
Maria Donatella Magri Italy 14 284 2.2× 150 1.6× 33 0.4× 22 0.5× 19 0.6× 44 564
Yasser El-Gohary United States 7 184 1.4× 97 1.0× 76 0.9× 22 0.5× 18 0.6× 12 423

Countries citing papers authored by Max Haid

Since Specialization
Citations

This map shows the geographic impact of Max Haid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Haid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Haid more than expected).

Fields of papers citing papers by Max Haid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Haid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Haid. The network helps show where Max Haid may publish in the future.

Co-authorship network of co-authors of Max Haid

This figure shows the co-authorship network connecting the top 25 collaborators of Max Haid. A scholar is included among the top collaborators of Max Haid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Haid. Max Haid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haid, Max, et al.. (2010). Establishing a Community-Based Lung Cancer Multidisciplinary Clinic As Part of a Large Integrated Health Care System: Aurora Health Care. Journal of Oncology Practice. 6(6). e27–e30. 32 indexed citations
2.
Haid, Max & Shankar Huprikar. (2001). Modulation of Germination and Growth of Plants by Meditation. The American Journal of Chinese Medicine. 29(03n04). 393–401. 5 indexed citations
3.
Sener, Stephen, Joseph L. Feldman, Carole Hennessy Martz, et al.. (2001). The Spectrum of Vascular Lesions in The Mammary Skin, Including Angiosarcoma, After Breast Conservation Treatment for Breast Cancer. Journal of the American College of Surgeons. 193(1). 22–28. 54 indexed citations
4.
Haid, Max, et al.. (1994). Digital rectal examination, serum prostate specific antigen, and prostatic ultrasound: How effective is this diagnostic triad?. Journal of Surgical Oncology. 56(1). 32–38. 5 indexed citations
5.
Haid, Max. (1992). Comprehensive Textbook of Oncology. JAMA. 267(4). 581–581. 40 indexed citations
6.
Haid, Max, R E Larson, & Michael Christ. (1992). Metastasis From Adenocarcinoma of the Lung Producing Acute Appendicitis. Southern Medical Journal. 85(3). 319–321. 17 indexed citations
7.
Gotti, Giuseppe, Piero Paladini, Massimo Maccherini, et al.. (1991). The survival in different N2 site infiltration in patients operated on for lung cancer. Lung Cancer. 7. 86–86. 2 indexed citations
8.
Gotti, Giuseppe, Piero Paladini, Massimo Maccherini, et al.. (1991). Segmentectomy, wedge resection and lobectomy for non small cell lung cancer. Lung Cancer. 7. 85–85. 1 indexed citations
9.
Haid, Max, et al.. (1988). Silicone elastomer catheter for chronic vascular access. Journal of Surgical Oncology. 37(2). 136–139. 6 indexed citations
10.
Haid, Max & Jeffrey S. Vender. (1988). Serum pseudocholinesterase levels in murine C3H mammary adenocarcinoma. Journal of Surgical Oncology. 37(3). 201–203. 2 indexed citations
11.
Dube, Volker E., et al.. (1987). An immunosorbent assay for blood group I antigens in breast carcinoma. Clinical Immunology and Immunopathology. 45(2). 196–207. 3 indexed citations
12.
Dube, Volker E., Max Haid, Joan S. Chmiel, & Byron Anderson. (1984). Serum cold agglutinin and IgM levels in breast carcinoma. Breast Cancer Research and Treatment. 4(2). 105–108. 6 indexed citations
13.
Haid, Max, Edward F. Scanlon, Janardan D. Khandekar, et al.. (1984). Treatment of breast carcinoma recurrent after adjuvant chemoimmunotherapy. Journal of Surgical Oncology. 26(4). 233–237. 4 indexed citations
14.
Haid, Max, Thomas A. Victor, C. Michael Weldon-Linne, & David N. Danforth. (1983). Malignant brenner tumor of the ovary: Electron microscopic study of a case responsive to radiation and chemotherapy. Cancer. 51(3). 498–508. 14 indexed citations
15.
Haid, Max, et al.. (1981). Peritoneal Washing Therapy for Pseudomyxoma Peritonei. Southern Medical Journal. 74(8). 913–915. 8 indexed citations
16.
Haid, Max, et al.. (1980). Liver scanning in newly diagnosed breast carcinoma. Journal of Surgical Oncology. 13(3). 265–268. 4 indexed citations
17.
Haid, Max, Jeffrey M. Ignatoff, Janardan D. Khandekar, John B. Graham, & James M. Holland. (1980). Urinary bladder metastases from breast carcinoma. Cancer. 46(1). 229–232. 19 indexed citations
18.
Haid, Max, et al.. (1977). Adriamycin-methotrexate combination chemotherapy of advanced carcinoma of the cervix.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 50(1). 103–5. 7 indexed citations
19.
Haid, Max, et al.. (1977). Thromboelastographic Distinction of Malignant From Benign Breast Masses. Southern Medical Journal. 70(7). 774–775. 8 indexed citations
20.
Haid, Max, et al.. (1976). Thromboelastographic changes in carcinoma: an animal model.. PubMed. 7(3-4). 189–216. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026